Scientist II, Analytical Development
- Employer
- Legend Biotech
- Location
- Somerset, New Jersey
- Posted date
- Sep 28, 2026
View more categories
- Discipline
- Information Technology, Science/R&D, Business/Data Analytics, Biotechnology
- Required Education
- Bachelors Degree
- Position Type
- Full time
By clicking apply, your email address will be shared with the employer.
Job Details
Legend Biotech is a global biotechnology company dedicated to treating and, one day, curing life-threatening diseases. Headquartered in Bridgewater, New Jersey, we are advancing the next generation of cell therapy through a portfolio of innovative technologies, including autologous, allogeneic, and in vivo cell therapy approaches. Our research spans chimeric antigen receptor T-cell (CAR-T), T-cell receptor (TCR-T), natural killer (NK) cell-based therapies, and other emerging platforms designed to transform the treatment of serious diseases. From our global network of research and development sites, we are committed to discovering and developing safe, effective, and cutting-edge therapies for patients worldwide.
Legend Biotech entered into a global collaboration agreement with Johnson & Johnson to jointly develop and commercialize CARVYKTI® (ciltacabtagene autoleucel; cilta-cel). Through this strategic partnership, we combine complementary expertise and capabilities to advance innovative immunotherapies for patients living with multiple myeloma.
Legend Biotech is seeking a Scientist II, Analytical Development as part of the Technical Development team based in Somerset, NJ.
Role Overview
We are seeking a dynamic and scientifically driven Scientist II to join Functional, Flow Cytometry and BioAnalytics team within our empowered Analytical Development organization. This role will focus on the establishment, development and qualification of analytical methods, including compendial methods, flow cytometry, cell-based potency, and immunoassays to support the development and manufacture of Legend’s cell and gene therapy pipeline. This laboratory-focused role will require that candidates develop, optimize and execute analytical methods for product characterization, release and stability testing. This role will require authoring and reviewing documents, maintaining electronic laboratory notebooks, and contributing to cross-functional collaboration with other functional teams.
Key Responsibilities
Develop, optimize, and execute analytical methods to support viral vector and CAR-T product characterization, including compendial methods, titer, particle size, flow cytometry, and cell-based potency methods.
Author and review methods, protocols, and reports.
Maintain reagent inventory and order materials as laboratory activities require.
Generate and qualify critical materials for analytical methods.
Observe all laboratory safety standards including PPE use and BSL2 best practices.
Performing pre-qualification, assay qualification, product release testing, and product characterization testing in a quality control environment.
Technology transfer of methods to QC and external collaborators and receive methods from internal and external collaborators.
Maintain contemporaneous and accurate electronic laboratory records, including instrument maintenance records and sample inventory, following ALCOA+ standards.
Perform peer review and data integrity reviews in the analytical development and quality control environments.
Collaborate cross-functionally with PD, QC and Manufacturing teams to ensure seamless assay execution, troubleshooting, and continuous improvement.
Present scientific data at internal and external forums.
Balance multiple projects while meeting established timelines.
This role is empowered to make decisions related to day-to-day planning and execution of assay development runs according to timelines determined at the group level. Collaboration, consensus and alignment with management are required for decisions related to methodology, assay development strategy, or interactions with other functional teams.
Requirements
Bachelor’s degree in a related field with 7 or more years of relevant experience, or Master’s degree with 5 to 7 years of experience, or PhD with 2 to 4 years of experience or relevant post-doctoral research.
Strong laboratory background, including experience with developing flow cytometry, mammalian cell culture, ELISA, and cell-based assays.
Experience implementing or executing compendial methods is preferred.
Experience with lentiviral vector characterization, including infectious titer, potency, and transduction efficacy assays.
Solid understanding of ICH guidelines and regulatory expectations for method qualification.
Experience with assay qualification, release testing and product characterization testing in a regulated environment.
Experience with document change management and document review/approval workflows is preferred.
Guide the establishing and authoring of SOPs/procedures for established methods
Detail-oriented with expertise in problem solving and solid decision-making abilities.
Excellent verbal and written communication skills.
Experience in:
Excel, Word, PowerPoint, etc
GraphPad Prism, other data analysis tools (PowerBI, JUMP, R)
CytoExpert, FCS express, NovoExpress, FlowJo, etc
ELN, LabVantage, etc
Language(s): Strong written and verbal English skills are required. Mandarin preferred.
AI Literacy: Possesses a working knowledge of AI technologies and approved AI tools, applies them responsibly to enhance productivity and decision-making, exercises appropriate human oversight of AI-generated outputs, and complies with organizational policies governing AI use.
#Li-JR1
#Li-Onsite
The base pay range below is what Legend Biotech USA Inc. reasonably expects to offer at the time of posting. Actual compensation may vary based on experience, skills, qualifications, and geographic location. The company reserves the right to modify this range as needed and in accordance with applicable laws.
Other Types of Pay: Performance-based bonus and/or equity is available to employees in eligible roles.
Benefits and Paid Time Off: Medical, dental, and vision insurance as well as a 401(k) retirement plan with a company match that vests fully on day one. We offer eight (8) weeks of paid parental leave after just three (3) months of employment, and a paid time off policy that includes vacation time, personal time, sick time, floating holidays, and eleven (11) company holidays. Additional voluntary benefits include flexible spending and health savings accounts, life and AD&D insurance, short- and long-term disability coverage, legal assistance, and supplemental plans such as pet, critical illness, accident, and hospital indemnity insurance. We also provide voluntary commuter benefits, family planning and care resources, well-being initiatives, and peer-to-peer recognition programs; demonstrating our ongoing commitment to building a culture where our people feel empowered, supported, and inspired to do their best work.
Pay Range (Base Pay):
$110,706 - $145,303USD
Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech.
Work Authorization & Employment Eligibility
Applicants must be authorized to work in the United States. As part of our commitment to maintaining a lawful workforce and ensuring compliance with federal employment regulations, we participate in the E-Verify program. If you are selected for employment, you will be required to complete the Form I-9 process, and your employment eligibility will be verified through E-Verify in accordance with applicable federal law. We are committed to providing a fair, transparent, and welcoming hiring experience for all candidates.
EEO Statement
It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances.
Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company.
For information related to our privacy notice, please review: Legend Biotech Privacy Notice.
Company
Legend Biotech was founded as an early-stage cell therapy company in 2014. The company was the brainchild of visionary scientists who recognized that antibody-based therapeutics could potentially treat disease and possessed the backgrounds in immunology and gene editing to take the leap.
For two years, Legend Biotech, then known as the “Legend Project,” operated in a room the size of a freight elevator, with the goal of creating a cell therapy for multiple myeloma, a hematological cancer that often relapses and can become refractory. The team produced nanobodies for single-domain antibody drugs and ultimately extended the half-life of the nanobodies with proprietary technologies.
In 2015, Legend’s scientists focused on research for chimeric antigen-receptor T-cells (CAR-T) targeting the BCMA protein, making the biotech one of the first companies in the world to engineer CAR-T cells for the BCMA protein. In 2016, investigator-initiated trials began in China.
In 2017, data from the trials were presented at the American Society for Clinical Oncology (ASCO), which led to a partnership with biopharmaceutical company Janssen Biotech, Inc. to co-develop the anti-BCMA CAR-T, ciltacabtagene autoleucel (cilta-cel). Applications seeking approval of cilta-cel for the treatment of patients with RRMM are currently under regulatory review by several health authorities around the world. CARVYKTI™ (ciltacabtagene autoleucel) was approved by the U.S. Food and Drug Administration in February 2022 and received conditional marketing approval from the European Medicines Agency in May 2022.
Today Legend Biotech is a global, commercial-stage company driven by a passion for patients. We continue to build our pipeline of cell therapy platforms, which includes CAR-T, CAR-NK, CAR-γδ T and non-gene-editing CAR technologies.
Our goal is to bring hope and opportunity to patients and their families by continuing to explore unique technologies.